MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
6.67 M |
Marktkapitalisierung |
$ 6.93 M |
EBITDA (LTM) |
$ -8.25 M |
P/E (LTM) |
-0.878049 |
P/S (LTM) |
124.143069 |
EPS (LTM) |
-1.23 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Aurinia Pharmaceuticals
AUPH
|
$ 15.83 | 0.49 % | $ 2.13 B | Nasdaq Global Market |  Canada |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.78 | 4.3 % | $ 474 M | Nasdaq Global Select Market |  Britain |
 |
Atea Pharmaceuticals
AVIR
|
$ 5.13 | 0.59 % | $ 418 M | Nasdaq Global Select Market | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
$ 1.82 | 0.43 % | $ 155 M | Nasdaq Capital Market | USA |
 |
Axon Enterprise
AXON
|
$ 413.35 | 0.25 % | $ 32.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Axsome Therapeutics
AXSM
|
$ 179.25 | 0.73 % | $ 8.92 B | Nasdaq Global Market,SPB | USA |
 |
Aytu BioScience
AYTU
|
$ 2.07 | 0.93 % | $ 25.5 M | Nasdaq Capital Market | USA |
 |
BridgeBio Pharma
BBIO
|
$ 67.25 | 0.51 % | $ 12.9 B | Nasdaq Global Select Market,SPB | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 8.17 | 0.62 % | $ 1.71 B | Nasdaq Global Select Market | USA |
 |
Bicycle Therapeutics plc
BCYC
|
$ 3.38 | 0.14 % | $ 234 M | Nasdaq Global Select Market | Britain |
 |
Black Diamond Therapeutics
BDTX
|
$ 1.89 | 0.53 % | $ 107 M | Nasdaq Global Select Market,SPB | USA |
 |
Beam Therapeutics
BEAM
|
$ 24.5 | 0.45 % | $ 2.42 B | Nasdaq Global Select Market | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 12.87 | 0.72 % | $ 832 M | NYSE | USA |
 |
Biogen
BIIB
|
$ 219.88 | 0.13 % | $ 32.2 B | Nasdaq Global Select Market,SPB | USA |
 |
BioVie
BIVI
|
$ 1.46 | 0.68 % | $ 2.16 M | Nasdaq Capital Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.34 | 0.43 % | $ 5.77 B | Nasdaq Capital Market |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
$ 57.18 | 0.22 % | $ 11 B | Nasdaq Global Select Market,SPB | USA |
 |
Bristol-Myers Squibb Company
BMY
|
$ 61.15 | 0.53 % | $ 124 B | NYSE,SPB | USA |
 |
Benitec Biopharma
BNTC
|
$ 8.98 | 2.56 % | $ 418 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 96.9 | 0.05 % | $ 23.4 B | Nasdaq Global Select Market |  Germany |
 |
Burford Capital Limited
BUR
|
$ 3.65 | 0.51 % | $ 800 M | NYSE | Britain |
 |
BeyondSpring
BYSI
|
$ 0.79 | 0.64 % | $ 32.5 M | Nasdaq Capital Market | USA |
 |
Cabaletta Bio
CABA
|
$ 2.0 | 5.82 % | $ 201 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 2.2 | 0.45 % | $ 3.62 M | NYSE American | Israel |
 |
Capricor Therapeutics
CAPR
|
$ 8.95 | 0.11 % | $ 416 M | Nasdaq Capital Market | USA |
 |
Catalyst Biosciences
CBIO
|
$ 14.32 | 0.42 % | $ 1.28 B | Nasdaq Capital Market | USA |
 |
C4 Therapeutics
CCCC
|
$ 2.95 | 0.32 % | $ 245 M | Nasdaq Global Select Market | USA |
 |
Zymeworks
ZYME
|
$ 25.15 | 0.46 % | $ 1.3 B | NYSE | Canada |
 |
Codexis
CDXS
|
$ 1.36 | 0.37 % | $ 119 M | Nasdaq Global Select Market | USA |
 |
Cerus Corporation
CERS
|
$ 2.28 | 1.29 % | $ 435 M | Nasdaq Global Market | USA |
 |
Certara
CERT
|
$ 9.36 | 0.21 % | $ 1.5 B | Nasdaq Global Select Market | USA |
 |
Cullinan Management
CGEM
|
$ 15.51 | 6.74 % | $ 934 M | Nasdaq Global Select Market | USA |
 |
Compugen Ltd.
CGEN
|
$ 2.31 | 0.43 % | $ 216 M | Nasdaq Global Market,SPB | Israel |
 |
Coherus BioSciences
CHRS
|
$ 1.16 | 0.86 % | $ 136 M | Nasdaq Global Market | USA |
 |
Celldex Therapeutics
CLDX
|
$ 31.65 | 0.56 % | $ 2.1 B | Nasdaq Global Select Market | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
$ 3.46 | 0.84 % | $ 42.2 M | Nasdaq Capital Market | Israel |
 |
Cellectis S.A.
CLLS
|
$ 1.43 | 2.14 % | $ 143 M | Nasdaq Global Market |  France |
 |
Cellectar Biosciences
CLRB
|
$ 1.78 | 0.53 % | $ 4.64 M | Nasdaq Capital Market | USA |
 |
CNS Pharmaceuticals
CNSP
|
$ 5.32 | 1.61 % | $ 2.36 M | Nasdaq Capital Market | USA |
 |
Cocrystal Pharma
COCP
|
$ 1.16 | 1.75 % | $ 13.1 M | Nasdaq Capital Market | USA |
 |
Collegium Pharmaceutical
COLL
|
$ 22.02 | 0.82 % | $ 697 M | Nasdaq Global Select Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 116.23 | 1.93 % | $ 12.1 B | Nasdaq Capital Market,SPB | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 6.13 | 0.16 % | $ 81.6 M | Nasdaq Global Market | USA |
 |
Cardiff Oncology
CRDF
|
$ 1.12 | 3.42 % | $ 74.9 M | Nasdaq Capital Market | USA |
 |
Curis
CRIS
|
$ 0.8 | 0.1 % | $ 10.5 M | Nasdaq Global Market | USA |
 |
CorMedix
CRMD
|
$ 7.19 | 0.51 % | $ 518 K | Nasdaq Global Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 55.43 | 0.25 % | $ 4.98 B | Nasdaq Global Market,SPB |  Schweiz |
 |
Corvus Pharmaceuticals
CRVS
|
$ 10.9 | 0.09 % | $ 861 M | Nasdaq Global Market | USA |
 |
Champions Oncology
CSBR
|
$ 4.94 | 1.23 % | $ 68.3 M | Nasdaq Capital Market | USA |